1Pilar C. Maria J, Alonso J, et al. Improved ocular bioavailahility of inomethacin by novel - ocular drug carries [J]. J Pharm Pharmacol, 1997, 49 (8) : 737 - 742.
5Giunchedi P, Conte U. Dectin microspheres as ophthalmic carries for piroxicam evaluation in vitro and in viva in albino rabbits[J]. Eur J Pharma Sci, 1999(9): 1 -7.
6Srividya B, A min PD, Cardoza RM. Sustained ophthalmic delivery of loxacin from a PH triggered in situ gelling system[J ]. J Contro Rel, 2001, 93(2 -3): 205 -211.
7AM De Campos, A Sanchez, MJ Alonso. Chitosam nanoparticles: a new vehicle for the improvement of delivey of drugs to ocular surface. Application to cyclosporin A[J]. inter J Pharm, 2001,224:145 - 168.
8Zimmer A, Kkreuter J. Microapheres and nanoparticles used in ocular delivery systems [ J ]. Adv Drug Deliv Rev, 1995, 16 ( 1 ) : 61 - 73.
9Taplin G V, Johnson D E. Suspensions of radioalbuumin aggregates for photoscanning the liver, spleen, lung and other organs[J]. J Nucl Med, 1964 (5) : 259 - 275.
5Taplin. G. V., Johnson, D. E., et al. Suspensions of radioalbumin aggregates for photoscanning the liver, spleen,lung and other organs. J. Nucl.Med, 1964(5) :259～ 275.
6R. Sutinen, V. Laasanen, P. Paronen, et al. pH-controlled silicone microspheres for controlled drug delivery. Journal of Controlled Release, 1995(33): 163～ 171.
7Andreas Zimmer,Jorg Kreuter. Microspheres and nanoparticles used in ocular delivery systems. Advanced Drug Delivery Reviews, 1995(16):61～73.
8Burgess. D.J., Davis. S. S., Tomlinson. E. Potential use of albumin microspheres as a drug delivery system I: Preparation and in vitro release of steroids. Int. J. Pham, 1987(39): 129～136.
9Kim. C. K., Oh. Y. K. Development of hydrophilic human serum albumin microspheres using a drug-albumin conjugate. Int. J.Pharm,1988(47): 163 169.
10Fickat. R. Benita. S., Puisieux. Preparation of biodegradable microspheres based on serum albumin. US 4666641.
